FUJIFILM Diosynth Biotechnologies is a dedicated biopharmaceutical CDMO business with development and manufacturing sites in the UK and in the USA, employing over 1000 staff.
FUJIFILM Diosynth Biotechnologies is a dedicated biopharmaceutical CDMO business with development and manufacturing sites in Billingham, UK and Research Triangle Park, North Carolina, USA, as well as College Station, TX, USA, in total employing over 1000 staff. FUJIFILM Diosynth Biotechnologies works with biotechnology and pharmaceutical companies across the globe that are developing new drugs to combat illnesses such as cancers, diabetes and rare diseases.
We have a strong mammalian track record that includes a 'gene to GMP' service, offering cell line and process development leading to cGMP manufacture for clinical and commercial product.
pAVEway™ is our proprietary and proven technology for the efficient expression of therapeutic proteins. It has recently been improved to permit large-scale protein manufacture using antibiotic-free microbial fermentations.
FUJIFILM Diosynth Biotechnologies' scientists have researched the key components in the generation of a recombinant cell line, and as a result have created our new Apollo™ mammalian expression platform.
Fujifilm Corporation is a wholly-owned subsidiary of Fujifilm Holdings Corporation.